Genetically Engineered Cellular Nanovesicle as Targeted DNase I Delivery System for the Clearance of Neutrophil Extracellular Traps in Acute Lung Injury
Advanced Science · 2023-11 · 10 (32)
DOI: 10.1002/advs.202303053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 27.09.2023. Verfasst von Yang Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 31000…. Hauptthemen laut MEDLINE: Extracellular Traps, Acute Lung Injury, Respiratory Distress Syndrome. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Program of Zhejiang Province, National Natural Science Foundation of China, Zhejiang University Basic Research Fund.
Abstract (Originalsprache)
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) are prevalent critical illnesses with a high mortality rate among patients in intensive care units. Neutrophil extracellular traps (NETs) are implicated in the pathogenesis of ALI/ARDS and represent a promising therapeutic target. However, the clinical application of deoxyribonuclease I (DNase I), the only drug currently available to clear NETs, is limited due to the lack of precise and efficient delivery strategies. Therefore, targeted delivery of DNase I to the inflamed lung remains a critical issue to be addressed. Herein, a novel biomimetic DNase I delivery system is developed (DCNV) that employs genetically and bioorthogonally engineered cellular nanovesicles for pulmonary NETs clearance. The CXC motif chemokine receptor 2 overexpressed cellular nanovesicles can mimic the inflammatory chemotaxis of neutrophils in ALI/ARDS, leading to enhanced lung accumulation. Furthermore, DNase I immobilized through bioorthogonal chemistry exhibits remarkable enzymatic activity in NETs degradation, thus restraining inflammation and safeguarding lung tissue in the lipopolysaccharide‐induced ALI murine model. Collectively, the findings present a groundbreaking proof‐of‐concept in the utilization of biomimetic cellular nanovesicles to deliver DNase I for treating ALI/ARDS. This innovative strategy may usher in a new era in the development of pharmacological interventions for various inflammation‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
- Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- National Innovation Center for Fundamental Research on Cancer Medicine, Hangzhou, Zhejiang, 310009, China.
- Cancer Center, Zhejiang University, Hangzhou, Zhejiang, 310058, China.
- ZJU-Pujian Research & Development Center of Medical Artificial Intelligence for Hepatobiliary and Pancreatic Disease, Hangzhou, Zhejiang, 310058, China.
ORCID-Profile: Zhengwei Mao
Förderung
- Key Research and Development Program of Zhejiang Province
- National Natural Science Foundation of China
- Zhejiang University Basic Research Fund
- Fundamental Research Funds for the Central Universities
- Zhejiang Provincial Natural Science Foundation of China
- Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province
- Zhejiang University K.P.Chao's High Technology Development Foundation
- Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province
Zitieren
APA
Du, Y., Chen, Y., Li, F., Mao, Z., Ding, Y., & Wang, W. (2023). Genetically Engineered Cellular Nanovesicle as Targeted DNase I Delivery System for the Clearance of Neutrophil Extracellular Traps in Acute Lung Injury. Advanced Science, 10(32). https://doi.org/10.1002/advs.202303053
Vancouver
Du Y, Chen Y, Li F, Mao Z, Ding Y, Wang W. Genetically Engineered Cellular Nanovesicle as Targeted DNase I Delivery System for the Clearance of Neutrophil Extracellular Traps in Acute Lung Injury. Advanced Science. 2023;10(32). doi:10.1002/advs.202303053
BibTeX
@article{Du2023,
author = {Du, Yang and Chen, Yining and Li, Fangyuan and Mao, Zhengwei and Ding, Yuan and Wang, Weilin},
title = {Genetically Engineered Cellular Nanovesicle as Targeted DNase I Delivery System for the Clearance of Neutrophil Extracellular Traps in Acute Lung Injury},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {32},
doi = {10.1002/advs.202303053}
}
EUVIMED